Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients

Vista sencilla de ítem
dc.contributor.authorLozano, Carlo
dc.contributor.authorCórdova, Claudio
dc.contributor.authorMarchant, Ivanny
dc.contributor.authorZúñiga, Rodrigo
dc.contributor.authorOchova, Paola
dc.contributor.authorRamírez-Barrantes, Ricardo
dc.contributor.authorGonzález-Arriagada, Wilfredo Alejandro
dc.contributor.authorRodriguez, Belén
dc.contributor.authorOlivero, Pablo
dc.date.accessioned2022-09-01T18:06:14Z
dc.date.available2022-09-01T18:06:14Z
dc.date.issued2018
dc.descriptionIndexación Scopuses
dc.description.abstractBackground: Breast cancer is a malignant disease that represents an important public health burden. The description of new molecular markers can be important to diagnosis, classification, and treatment. Transient receptor potential vanilloid 1 (TRPV1) polymodal channel is expressed in different neoplastic tissues and cell lines of breast cancer and associated with the regulation of tumor growth, tumor neurogenesis, cancer pain, and malignant progression of cancer. In primary and metastatic breast cancer tumors, TRPV1 is expressed during neoplastic transformation, invasive behavior, and resistance to cytotoxic therapy. Objective: The objective of this study was to describe the subcellular distribution of TRPV1 in invasive breast carcinomas and its association with survival. Methods: In 33 cases of invasive breast carcinomas, we identified immunohistochemical and immunofluorescent expression patterns of TRPV1 compared to healthy breast tissue. We characterized the expression of TRPV1 induced by estrogens in breast cancer cell lines MCF-7 and MDA to establish a model of the TRPV1–estrogen relationship regarding the malignant potential. We examined the association of TRPV1 patterns with patients’ survival with the Kaplan–Meyer model, using the log-rank test at 5 years of follow-up. The relation of TRPV1 expression patterns to the St. Gallen breast cancer subtypes was also tested. Results: Based on immunohistochemical expression pattern of TRPV1, we distinguished two main categories of breast cancer tissue, a “classical category” that exhibited diffuse expression of the channel and a “non-classical category” that expressed the channel in aggregates at the ER/Golgi and/or surrounding these structures. The classical pattern of TRPV1 was associated with a higher survival rate. In breast cancer cell lines, increasing doses of estrogens induced increased TRPV1 expression with nonclassical patterns at higher doses via a mechanism dependent on ER α. Conclusion: The expression and distribution of TRPV1 in invasive breast carcinomas may be considered as a biomarker for prognosis of the disease and a probable therapeutic target. © 2018 Lozano et al.es
dc.description.urihttps://www.dovepress.com/intracellular-aggregated-trpv1-is-associated-with-lower-survival-in-br-peer-reviewed-fulltext-article-BCTT
dc.identifier.citationBreast Cancer: Targets and Therapy Volume 10, Pages 161 - 168 2018es
dc.identifier.doi10.2147/BCTT.S170208
dc.identifier.issn11791314
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/23714
dc.language.isoenes
dc.publisherDove Medical Press Ltd.es
dc.rights.licenseCC BY-NC 4.0
dc.subjectTransient Receptor Potential Channelses
dc.subjectAnimalses
dc.subjectRN 1734es
dc.subjectBreast cancer prognosises
dc.subjectCapsaicin receptorses
dc.subjectImmunohistochemistryes
dc.subjectVanilloid receptorses
dc.titleIntracellular aggregated TRPV1 is associated with lower survival in breast cancer patientses
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Lozano_C_Intracellular_2018.pdf
Tamaño:
3.5 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
FM - Artículos de Revista